Clinical study of homoeopathic treatment in the management of Prostate enlargement.
Phase 3
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2024/04/065820
- Lead Sponsor
- Sai Bhaskar D
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who fulfill the case definition.
Patients aged 40 years and above will be included in the study.
Only symptomatic patients will be taken into the study.
Patients without any advanced systemic illnesses.
Patients willing to participate in the study and willing to sign the informed consent.
Exclusion Criteria
Patients with IPSS score of greater than 20 (severe BPH) requiring surgical intervention.
Patients with Hematuria will not be taken into the study.
Patients with Vesical Calculi (Urinary bladder stones).
Patients under any other medications for BPH.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To ascertain the effectiveness of Individualized Homoeopathic medicines in cases of BPH and clinically assess the outcome by using IPSS, BII (BPH Impact Index) which is a Quality of Life index, every 15 days.Timepoint: The patient will be followed up every 15 days and his IPSS score and BII scores will be recorded every 15 days to assess the effect of the given treatment and the progress of the condition.
- Secondary Outcome Measures
Name Time Method To assess the variation in Post-void Residual Volume (PVR volume) by USG pelvis before and after the treatment.Timepoint: Every patient will be under Homoeopathic treatment for 3 months and USG Pelvis will be recorded before and after the 3 months of treatment to assess the variation in the PVR volume.